Schranz Jennifer 4
4 · Nabriva Therapeutics plc · Filed Mar 2, 2021
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2021-02-28$2.39/sh−33$79→ 39,125 total
Footnotes (1)
- [F1]These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.